ATE418545T1 - Nnrt-inhibitoren - Google Patents
Nnrt-inhibitorenInfo
- Publication number
- ATE418545T1 ATE418545T1 AT06793671T AT06793671T ATE418545T1 AT E418545 T1 ATE418545 T1 AT E418545T1 AT 06793671 T AT06793671 T AT 06793671T AT 06793671 T AT06793671 T AT 06793671T AT E418545 T1 ATE418545 T1 AT E418545T1
- Authority
- AT
- Austria
- Prior art keywords
- nnrt
- inhibitors
- nnrt inhibitors
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
- C07D273/04—Six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72233505P | 2005-09-30 | 2005-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE418545T1 true ATE418545T1 (de) | 2009-01-15 |
Family
ID=37685915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06793671T ATE418545T1 (de) | 2005-09-30 | 2006-09-20 | Nnrt-inhibitoren |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7625897B2 (de) |
| EP (1) | EP1937651B1 (de) |
| JP (1) | JP2009510013A (de) |
| KR (1) | KR20080064957A (de) |
| CN (1) | CN101273020A (de) |
| AR (1) | AR055666A1 (de) |
| AT (1) | ATE418545T1 (de) |
| AU (1) | AU2006298853A1 (de) |
| BR (1) | BRPI0617205A2 (de) |
| CA (1) | CA2623728A1 (de) |
| DE (1) | DE602006004473D1 (de) |
| ES (1) | ES2317584T3 (de) |
| IL (1) | IL190081A0 (de) |
| TW (1) | TW200800923A (de) |
| WO (1) | WO2007039463A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7834178B2 (en) * | 2006-03-01 | 2010-11-16 | Bristol-Myers Squibb Company | Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors |
| GB0610680D0 (en) * | 2006-05-31 | 2006-07-12 | Istituto Di Ricerche D Biolog | Therapeutic compounds |
| CL2007002105A1 (es) * | 2006-07-21 | 2008-02-22 | Hoffmann La Roche | Compuestos derivados de 2-[3-(3-cianofenoxi)(fenoxi o fenilsulfanil)]-n-fenil acetamida, inhibidores de la transcriptasa inversa del vih; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar u |
| KR101401811B1 (ko) * | 2006-08-16 | 2014-05-29 | 에프. 호프만-라 로슈 아게 | 비-뉴클레오사이드 역전사효소 저해제 |
| AU2008257771B2 (en) | 2007-05-30 | 2015-02-19 | F. Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors |
| KR20100039348A (ko) * | 2007-06-22 | 2010-04-15 | 에프. 호프만-라 로슈 아게 | 비-뉴클레오사이드 역 전사효소 억제제로서 우레아 및 카바메이트 유도체 |
| CN101903382B (zh) * | 2007-12-21 | 2012-11-28 | 弗·哈夫曼-拉罗切有限公司 | 杂环抗病毒化合物 |
| TWI490214B (zh) | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途 |
| AU2009331660A1 (en) * | 2008-12-22 | 2011-06-30 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0835104A4 (de) | 1995-06-30 | 1999-10-20 | Smithkline Beecham Corp | Verwendung von stat 5 sh2 domaine spezifischer verbindungen zur förderung der erythropoese |
| CN1136197C (zh) | 1996-05-30 | 2004-01-28 | 霍夫曼-拉罗奇有限公司 | 新的哒嗪酮衍生物 |
| TW200505441A (en) * | 2003-03-24 | 2005-02-16 | Hoffmann La Roche | Non-nucleoside reverse transcriptase inhibitorsⅠ |
| CA2518823A1 (en) * | 2003-03-24 | 2004-10-07 | F.Hoffmann-La Roche Ag | Benzyl-pyridazinons as reverse transcriptase inhibitors |
| CN1934092A (zh) | 2004-03-23 | 2007-03-21 | 弗·哈夫曼-拉罗切有限公司 | 非核苷逆转录酶抑制剂 |
-
2006
- 2006-09-20 DE DE602006004473T patent/DE602006004473D1/de active Active
- 2006-09-20 BR BRPI0617205-9A patent/BRPI0617205A2/pt not_active Application Discontinuation
- 2006-09-20 CA CA002623728A patent/CA2623728A1/en not_active Abandoned
- 2006-09-20 KR KR1020087010129A patent/KR20080064957A/ko not_active Withdrawn
- 2006-09-20 JP JP2008532729A patent/JP2009510013A/ja active Pending
- 2006-09-20 WO PCT/EP2006/066541 patent/WO2007039463A1/en not_active Ceased
- 2006-09-20 ES ES06793671T patent/ES2317584T3/es active Active
- 2006-09-20 CN CNA2006800353153A patent/CN101273020A/zh active Pending
- 2006-09-20 EP EP06793671A patent/EP1937651B1/de not_active Not-in-force
- 2006-09-20 AU AU2006298853A patent/AU2006298853A1/en not_active Abandoned
- 2006-09-20 AT AT06793671T patent/ATE418545T1/de not_active IP Right Cessation
- 2006-09-27 TW TW095135814A patent/TW200800923A/zh unknown
- 2006-09-28 AR ARP060104260A patent/AR055666A1/es not_active Application Discontinuation
- 2006-09-29 US US11/541,011 patent/US7625897B2/en not_active Expired - Fee Related
-
2008
- 2008-03-11 IL IL190081A patent/IL190081A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1937651B1 (de) | 2008-12-24 |
| ES2317584T3 (es) | 2009-04-16 |
| US20070078128A1 (en) | 2007-04-05 |
| AR055666A1 (es) | 2007-08-29 |
| EP1937651A1 (de) | 2008-07-02 |
| KR20080064957A (ko) | 2008-07-10 |
| DE602006004473D1 (de) | 2009-02-05 |
| WO2007039463A1 (en) | 2007-04-12 |
| TW200800923A (en) | 2008-01-01 |
| AU2006298853A1 (en) | 2007-04-12 |
| BRPI0617205A2 (pt) | 2011-07-19 |
| IL190081A0 (en) | 2008-08-07 |
| US7625897B2 (en) | 2009-12-01 |
| JP2009510013A (ja) | 2009-03-12 |
| CA2623728A1 (en) | 2007-04-12 |
| CN101273020A (zh) | 2008-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2021013I1 (el) | Δι-αρυλ μετα-πυριμιδινο αναστολεις κινασων | |
| DK2041138T3 (da) | Pyrroltriazinkinase-inhibitorer | |
| DK2024375T3 (da) | Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere | |
| NO20076678L (no) | Glutamataggrekanaseinhibitorer | |
| LTC2178888I2 (lt) | Proteazomos inhibitoriai | |
| CR10831A (es) | INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA | |
| DK1940839T3 (da) | Pyridopyrimidione Inhibitors of P13Ka | |
| EP1973889A4 (de) | Cetp-inhibitoren | |
| EP1971595A4 (de) | Cetp-inhibitoren | |
| BRPI0807547A2 (pt) | Inibidores de aspartil protease hetercíclicos | |
| DK1962830T3 (da) | Azaindolhæmmere af aurorakinaser. | |
| DK1979356T3 (da) | Carbonylaminopyrrolopyrazoler, kraftige kinaseinhibitorer | |
| DK2086939T3 (da) | Pyridiacarboxamid som II-beta-HSDI-inhibitorer | |
| BRPI0719204A2 (pt) | Inibidores de hdac | |
| PT1586571E (pt) | Inibidores da dipeptidil-peptidase | |
| DK2253614T3 (da) | IAP-inhibitorer | |
| DK1778718T3 (da) | Iap-inhibitorer | |
| DK1934236T3 (da) | Heterobifunktionelle pan-selektininhibitorer | |
| EP2051707A4 (de) | Plasma-kallikrein-hemmer | |
| DK2074108T3 (da) | Renin-inhibitorer | |
| EP2043672A4 (de) | Selektive caspase-hemmer | |
| DK2066662T3 (da) | Serinhydrolaseinhibitorer | |
| ATE493403T1 (de) | Kinaseinhibitoren | |
| IL190081A0 (en) | Nnrt inhibitors | |
| EP2177529A4 (de) | Neuer sekretasehemmer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |